​
​

Lucy Scientific Discovery Stock (NASDAQ:LSDI)

RevenueFinancialsChart

Previous Close

$0.67

52W Range

$0.44 - $12.80

50D Avg

$0.88

200D Avg

$2.28

Market Cap

$906.91K

Avg Vol (3M)

$1.23M

Beta

0.71

Div Yield

-

LSDI Company Profile

Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

2

IPO Date

Feb 09, 2023

Website

LSDI Performance

LSDI Financial Summary

Jun 23Jun 22Jun 21
Revenue$7.05K--
Operating Income$-5.84M$-3.79M$-2.49M
Net Income$-8.99M$-6.18M$-7.10M
EBITDA$-5.66M$-3.47M$-2.49M
Basic EPS-$-0.38$-0.44
Diluted EPS-$-0.38$-0.44

Fiscal year ends in Jun 23 | Currency in USD

Peer Comparison

TickerCompany
AKANAkanda Corp.
TLRYTilray Brands, Inc.
LFCRLifecore Biomedical, Inc.
ORGOOrganogenesis Holdings Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
ADMPAdamis Pharmaceuticals Corporation
CYTHCyclo Therapeutics, Inc.
CTLTCatalent, Inc.